Literature DB >> 1774312

Normally saprobic cryptococci isolated from Cryptococcus neoformans infections.

S Krajden1, R C Summerbell, J Kane, I F Salkin, M E Kemna, M G Rinaldi, M Fuksa, E Spratt, C Rodriguez, C Rodrigues.   

Abstract

We report two cases in which Cryptococcus laurentii was isolated from surgically resected pulmonary lesions but the cryptococcal cells is tissue reacted positively with a specific fluorescent antibody (FA) conjugate for Cryptococcus neoformans. Both patients had no apparent host defense defects. In both cases, multiple cryptococcal isolates were obtained from tissue, and yeastlike cells consistent with C. neoformans were seen in direct histology. The isolates were identified by assimilation patterns and standard procedures including phenoloxidase reactions. Since C. laurentii was consistently isolated by using stringent procedures, it was considered unlikely that the fungus represented surgical or laboratory contamination. Its presence may be the result of dual infection not detected by FA, but other possible explanations exist. The results show the value of the FA test in diagnostic mycology and call into question previous reports of cryptococci other than C. neoformans as agents of infection.

Entities:  

Mesh:

Year:  1991        PMID: 1774312      PMCID: PMC270229          DOI: 10.1128/jcm.29.9.1883-1887.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Studies on the fungal flora in the lung of human necropsy cases. A critical survey in connection with the pathogenesis of opportunistic fungus infections.

Authors:  M Okudaira; H Kurata; F Sakabe
Journal:  Mycopathologia       Date:  1977-07-29       Impact factor: 2.574

2.  Fungal spores in lung and sputum.

Authors:  J Mullins; A Seaton
Journal:  Clin Allergy       Date:  1978-09

3.  Pulmonary cryptococcosis. A case due to Cryptococcus albidus.

Authors:  M A Gordon
Journal:  Am Rev Respir Dis       Date:  1972-11

4.  [Pathogenicity of Crytococcus albidus].

Authors:  H G Wieser
Journal:  Schweiz Med Wochenschr       Date:  1973-03-31

5.  Cryptococcus albidus meningitis.

Authors:  T da Cunha; J Lusins
Journal:  South Med J       Date:  1973-11       Impact factor: 0.954

6.  Pulmonary cryptococcosis. A case due to Cryptococcus albidus.

Authors:  R A Krumholz
Journal:  Am Rev Respir Dis       Date:  1972-03

7.  Cryptococcus albidus meningitis.

Authors:  J C Melo; S Srinivasan; M L Scott; M J Raff
Journal:  J Infect       Date:  1980-03       Impact factor: 6.072

8.  Cutaneous infection by Cryptococcus laurentii.

Authors:  A Kamalam; P Yesudian; A S Thambiah
Journal:  Br J Dermatol       Date:  1977-08       Impact factor: 9.302

9.  Cryptococcus laurentii lung abscess.

Authors:  J P Lynch; D R Schaberg; D G Kissner; C A Kauffman
Journal:  Am Rev Respir Dis       Date:  1981-01

10.  Cryptococcemia due to Cryptococcus albidus.

Authors:  J L Gluck; J P Myers; L M Pass
Journal:  South Med J       Date:  1987-04       Impact factor: 0.954

View more
  10 in total

Review 1.  Developments in fungal taxonomy.

Authors:  J Guarro; A M Stchigel
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

2.  Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India.

Authors:  Piyali Mandal; Uma Banerjee; Arturo Casadevall; Joshua D Nosanchuk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  A rapid urease test for presumptive identification of Cryptococcus neoformans.

Authors:  C E Canteros; L Rodero; M C Rivas; G Davel
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

4.  Extracellular enzymatic activity in 11 Cryptococcus species.

Authors:  P García-Martos; P Marín; J M Hernández-Molina; L García-Agudo; S Aoufi; J Mira
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

5.  Cryptococcus laurentii biofilms: structure, development and antifungal drug resistance.

Authors:  K Ajesh; K Sreejith
Journal:  Mycopathologia       Date:  2012-09-01       Impact factor: 2.574

6.  Serological relationships of Cryptococcus spp.: distribution of antigenic factors in Cryptococcus and intraspecies diversity.

Authors:  R Ikeda; T Sugita; T Shinoda
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Mixed infections and In Vivo evolution in the human fungal pathogen Cryptococcus neoformans.

Authors:  Marie Desnos-Ollivier; Sweta Patel; Adam R Spaulding; Caroline Charlier; Dea Garcia-Hermoso; Kirsten Nielsen; Françoise Dromer
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

8.  Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.

Authors:  A Serda Kantarcioğlu; Teun Boekhout; G Sybren De Hoog; Bart Theelen; Ayhan Yücel; Tuba R Ekmekci; Bettina C Fries; Reiko Ikeda; Adem Koslu; Kemal Altas
Journal:  Med Mycol       Date:  2007-03       Impact factor: 4.076

Review 9.  Gastro-oesophageal reflux disease.

Authors:  Ronnie Fass; Guy E Boeckxstaens; Hashem El-Serag; Rachel Rosen; Daniel Sifrim; Michael F Vaezi
Journal:  Nat Rev Dis Primers       Date:  2021-07-29       Impact factor: 52.329

10.  Risk Factors for Cryptococcal Meningitis Recurrence in Human Immunodeficiency Virus (HIV)-Infected Patients in a Large Chinese Acquired Immune Deficiency Syndrome (AIDS) Treatment Center.

Authors:  Yue Zhou; Feng Li; Rui Li; Yuan Peng; Mei He; Fengjun Sun; Ming Yang
Journal:  Med Sci Monit       Date:  2021-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.